Clinical Practice Guidelines for Weight Management in Postpartum Women: An AIIMS-DST Initiative in Association with FOGSI
More than 100 million American adults live with obesity, and the arrival of GLP-1 receptor agonists like semaglutide and tirzepatide has triggered an unprecedented surge in patient demand
Direct comparison trials between the two are still running
Dungan KM, Weitgasser R, Perez Manghi F, Pintilei E, Fahrbach JL, Jiang HH, et al
Quick Answer: Patients on GLP-1 medications should aim for approximately 91-125 ounces of total daily fluid intake (2.7-3.7 liters), with adjustments based on individual factors like body weight, activity level, and gastrointestinal symptoms
Many patients naturally gravitate toward lighter, more protein-rich meals